Connor Clark & Lunn Investment Management Ltd. Cuts Stock Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Connor Clark & Lunn Investment Management Ltd. reduced its position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 67.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 85,758 shares of the company's stock after selling 177,652 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.10% of Pediatrix Medical Group worth $1,125,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of MD. Pacer Advisors Inc. bought a new stake in Pediatrix Medical Group in the fourth quarter worth approximately $35,492,000. Weiss Asset Management LP grew its position in shares of Pediatrix Medical Group by 50.5% during the 3rd quarter. Weiss Asset Management LP now owns 912,818 shares of the company's stock worth $10,580,000 after buying an additional 306,143 shares during the period. Raymond James Financial Inc. bought a new stake in shares of Pediatrix Medical Group in the 4th quarter valued at $3,066,000. RBF Capital LLC acquired a new position in shares of Pediatrix Medical Group during the 3rd quarter valued at $1,695,000. Finally, Rubric Capital Management LP boosted its stake in Pediatrix Medical Group by 1.5% during the third quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company's stock worth $95,907,000 after acquiring an additional 125,000 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Up 2.1 %

Shares of NYSE:MD traded up $0.30 during mid-day trading on Monday, hitting $14.51. 593,809 shares of the company traded hands, compared to its average volume of 811,255. The stock has a 50-day moving average price of $14.31 and a two-hundred day moving average price of $13.55. Pediatrix Medical Group, Inc. has a 12-month low of $6.62 and a 12-month high of $17.67. The stock has a market cap of $1.25 billion, a P/E ratio of -12.09, a P/E/G ratio of 1.74 and a beta of 1.49. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81.

Remove Ads

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.12. The firm had revenue of $502.36 million for the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. On average, equities research analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Wall Street Analyst Weigh In

MD has been the topic of several research reports. Macquarie started coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They set an "outperform" rating and a $18.00 price objective on the stock. StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. Truist Financial upped their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a research report on Friday, February 21st. Finally, UBS Group lifted their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research report on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $17.08.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.